Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with a History of Frequent COPD research hub

A Multicenter, Randomized, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab 100 mg in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with a History of Frequent COPD Exacerbations and Elevated Peripheral Blood Eosinophils (RESOLUTE)

This study is testing a new medicine, benralizumab, for people with moderate to very severe COPD who have frequent flare-ups and high levels of a certain type of white blood cell called eosinophils. It aims to see if the medicine can reduce these flare-ups and if it's safe.